30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q13 Revenue: aap Implantate

€9.2MM (~US $12.2MM), +1% (Trauma ~$3.7MM, +155%)

  • OEM sales of bone cement/cementing techniques down slightly, offset by strong LOQTEQ and biomaterials sales
  • Divested non-core recon products (hip, knee, shoulder)